HELP
Helus Pharma Inc. - Common Stock (HELP)
$20
About Helus Pharma Inc. - Common Stock (HELP)
Helus Pharma, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.
Details
Daily high
$8.07
Daily low
$7.03
Price at open
$7.81
52 Week High
$15.15
52 Week Low
$3.76
Market cap
560.4M
Dividend yield
-
Volume
3.0M
Avg. volume
2.0M
P/E ratio
-1.80
Helus Pharma Inc. - Common Stock News
Details
Daily high
$8.07
Daily low
$7.03
Price at open
$7.81
52 Week High
$15.15
52 Week Low
$3.76
Market cap
560.4M
Dividend yield
-
Volume
3.0M
Avg. volume
2.0M
P/E ratio
-1.80